141 related articles for article (PubMed ID: 15531466)
21. Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia.
Colovic N; Tosic N; Aveic S; Djuric M; Milic N; Bumbasirevic V; Colovic M; Pavlovic S
Ann Hematol; 2007 Oct; 86(10):741-7. PubMed ID: 17579862
[TBL] [Abstract][Full Text] [Related]
22. Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer?
Camps C; Sirera R; Bremnes R; Blasco A; Sancho E; Bayo P; Safont MJ; Sánchez JJ; Tarón M; Rosell R
Lung Cancer; 2005 Dec; 50(3):339-46. PubMed ID: 16139926
[TBL] [Abstract][Full Text] [Related]
23. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
[TBL] [Abstract][Full Text] [Related]
24. Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association.
Renneville A; Boissel N; Zurawski V; Llopis L; Biggio V; Nibourel O; Philippe N; Thomas X; Dombret H; Preudhomme C
Cancer; 2009 Aug; 115(16):3719-27. PubMed ID: 19536888
[TBL] [Abstract][Full Text] [Related]
25. Clonal analysis of multiple point mutations in the N-ras gene in patients with acute myeloid leukemia.
Kubo K; Naoe T; Kiyoi H; Fukutani H; Kato Y; Oguri T; Yamamori S; Akatsuka Y; Kodera Y; Ohno R
Jpn J Cancer Res; 1993 Apr; 84(4):379-87. PubMed ID: 8514604
[TBL] [Abstract][Full Text] [Related]
26. Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances.
Mrózek K; Döhner H; Bloomfield CD
Curr Opin Hematol; 2007 Mar; 14(2):106-14. PubMed ID: 17255787
[TBL] [Abstract][Full Text] [Related]
27. c-fms point mutations in acute myeloid leukemia: fact or fiction?
Springall F; O'Mara S; Shounan Y; Todd A; Ford D; Iland H
Leukemia; 1993 Jul; 7(7):978-85. PubMed ID: 8321048
[TBL] [Abstract][Full Text] [Related]
28. ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients.
van der Holt B; Van den Heuvel-Eibrink MM; Van Schaik RH; van der Heiden IP; Wiemer EA; Vossebeld PJ; Löwenberg B; Sonneveld P
Clin Pharmacol Ther; 2006 Nov; 80(5):427-39. PubMed ID: 17112800
[TBL] [Abstract][Full Text] [Related]
29. BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications.
Baldus CD; Thiede C; Soucek S; Bloomfield CD; Thiel E; Ehninger G
J Clin Oncol; 2006 Feb; 24(5):790-7. PubMed ID: 16418499
[TBL] [Abstract][Full Text] [Related]
30. Development of a human acute myeloid leukaemia screening panel and consequent identification of novel gene mutation in FLT3 and CCND3.
Smith ML; Arch R; Smith LL; Bainton N; Neat M; Taylor C; Bonnet D; Cavenagh JD; Andrew Lister T; Fitzgibbon J
Br J Haematol; 2005 Feb; 128(3):318-23. PubMed ID: 15667533
[TBL] [Abstract][Full Text] [Related]
31. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
32. Multivariate analyses of prognostic factors in acute myeloid leukemia: relevance of cytogenetic abnormalities and CD34 expression.
Junghanss C; Waak M; Knopp A; Kleine HD; Kundt G; Leithäuser M; Hilgendorf I; Wolff D; Casper J; Freund M
Neoplasma; 2005; 52(5):402-10. PubMed ID: 16151585
[TBL] [Abstract][Full Text] [Related]
33. Activation of the RAS pathway is predictive for a chemosensitive phenotype of acute myelogenous leukemia blasts.
Illmer T; Thiede C; Fredersdorf A; Stadler S; Neubauer A; Ehninger G; Schaich M
Clin Cancer Res; 2005 May; 11(9):3217-24. PubMed ID: 15867216
[TBL] [Abstract][Full Text] [Related]
34. Mutations in ras proto-oncogenes are associated with lower mdr1 gene expression in adult acute myeloid leukaemia.
Schaich M; Ritter M; Illmer T; Lisske P; Thiede C; Schäkel U; Mohr B; Ehninger G; Neubauer A
Br J Haematol; 2001 Feb; 112(2):300-7. PubMed ID: 11167822
[TBL] [Abstract][Full Text] [Related]
35. Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.
Paschka P; Marcucci G; Ruppert AS; Mrózek K; Chen H; Kittles RA; Vukosavljevic T; Perrotti D; Vardiman JW; Carroll AJ; Kolitz JE; Larson RA; Bloomfield CD;
J Clin Oncol; 2006 Aug; 24(24):3904-11. PubMed ID: 16921041
[TBL] [Abstract][Full Text] [Related]
36. Occurrence of point mutations in p53 gene is not increased in patients with acute myeloid leukaemia carrying an activating N-ras mutation.
Bühler-Leclerc M; Gratwohl A; Senn HP
Br J Haematol; 1993 Jul; 84(3):443-50. PubMed ID: 8217795
[TBL] [Abstract][Full Text] [Related]
37. N-ras gene point mutations in Brazilian acute myelogenous leukemia patients correlate with a poor prognosis.
De Melo MB; Lorand-Metze I; Lima CS; Saad ST; Costa FF
Leuk Lymphoma; 1997 Jan; 24(3-4):309-17. PubMed ID: 9156660
[TBL] [Abstract][Full Text] [Related]
38. Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution.
Chou WC; Tang JL; Lin LI; Yao M; Tsay W; Chen CY; Wu SJ; Huang CF; Chiou RJ; Tseng MH; Lin DT; Lin KH; Chen YC; Tien HF
Cancer Res; 2006 Mar; 66(6):3310-6. PubMed ID: 16540685
[TBL] [Abstract][Full Text] [Related]
39. Mutations of AML1 in non-M0 acute myeloid leukemia: six novel mutations and a high incidence of cooperative events in a South-east Asian population.
Auewarakul CU; Leecharendkeat A; Thongnoppakhun W; Limwongse C; Tocharoentanaphol C
Haematologica; 2006 May; 91(5):675-8. PubMed ID: 16627249
[TBL] [Abstract][Full Text] [Related]
40. Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutations.
Fröhling S; Schlenk RF; Krauter J; Thiede C; Ehninger G; Haase D; Harder L; Kreitmeier S; Scholl C; Caligiuri MA; Bloomfield CD; Döhner H; Döhner K
Genes Chromosomes Cancer; 2005 Apr; 42(4):427-32. PubMed ID: 15645492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]